TRANSVAC is a collaborative infrastructure project funded by the European Commission and coordinated by the European Vaccine Initiative (EVI). TRANSVAC offers high quality technical, free services to support the development of human and veterinary vaccines for prophylaxis and therapy. Academic and non-academic research groups, including small and medium-sized enterprises, can apply to benefit from the expertise, reagents, and facilities offered by TRANSVAC2 to accelerate the development of their vaccine. The webinar will give an overview about TRANSVAC, the services it offers and how you can apply for them.